Slide 1
Slide 2
Slide 3
Slide 4
*In clinical trials studying Wegovy® (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone). Results may vary. Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider’s prescription.

MOTS-C Metabolic Protocol

Supports metabolic flexibility, insulin sensitivity, and energy regulation — signals your mitochondria naturally produce during exercise.
Starting at $XXX/month
Activates AMPK — the same pathway targeted by metformin
Activates AMPK, the pathway targeted by metformin
Plasma levels decline with age and correlate with metabolic health markers
Plasma levels decline with age
Characterized as a natural "exercise signal" produced by mitochondria
Characterized as a natural "exercise signal"
MOTS-C is a 16-amino acid peptide discovered at USC in 2015 and encoded within the mitochondrial genome. Researchers have identified it as a key AMPK activator — a cellular energy regulator shared with metformin — with plasma levels that decline measurably with age.
*In clinical trials studying Wegovy® (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone). Results may vary. Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider’s prescription.
FAQ

Is MOTS-C FDA approved?

No. MOTS-C is investigational with no published human intervention trials yet. Shed is transparent about this being one of our most frontier protocols.
FAQ

Do I need labs first?

FAQ

How long is a protocol?

FAQ

How is it delivered?

  Physician Supervised  •  Lab-Monitored  •  FDA-Registered Pharmacy  •  Evidence-Reviewed  •
 Physician Supervised  •  Lab-Monitored  •  FDA-Registered Pharmacy  •  Evidence-Reviewed  •
  Physician Supervised  •  Lab-Monitored  •  FDA-Registered Pharmacy  •  Evidence-Reviewed  •
What is MOTS-C?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid peptide discovered by researchers at the University of Southern California in 2015 — one of a new class of "mitokines" encoded within the mitochondrial genome that communicate metabolic status to the rest of the body.

MOTS-C rises naturally during exercise and metabolic stress, acting as an endogenous signal that promotes glucose uptake, fatty acid oxidation, and stress resilience through AMPK activation. Plasma MOTS-C levels decline measurably with age and are lower in individuals with type 2 diabetes and elevated BMI — leading researchers to describe it as a potential metabolic longevity signal.

A 2021 *Nature Aging* study revealed MOTS-C also translocates to the nucleus under metabolic stress, coordinating mitochondrial and nuclear gene expression during adaptation — expanding its understood role significantly.

Benefit deep dive

Heading

Daily support to help maintain cellular energy.

AMPK Activation

MOTS-C activates AMPK — the master cellular energy sensor — promoting glucose uptake in muscle, stimulating fatty acid oxidation, and suppressing energy-wasting processes. This is the same pathway targeted by metformin, one of the most-studied longevity compounds.

Metabolic Flexibility

Exercise Signal Mimicry

Age-Related Decline Marker

Individual experiences vary. These statements describe general physiological roles of NAD+.

How MOTS-C Works

Designed to support circulation and the body’s natural recovery pathways
1.
Mitochondrial-Nuclear Communication

MOTS-C is released from mitochondria and translocates to the nucleus under metabolic stress — where it acts as a transcriptional regulator coordinating gene expression across both genomes during adaptation.

2.
AMPK Signaling

MOTS-C activates AMPK, which phosphorylates downstream targets involved in glucose transport, fatty acid oxidation, mitochondrial biogenesis, and cellular energy homeostasis

3.
Folate Cycle Interaction

Research identified MOTS-C interferes with the folate cycle in mitochondria, producing a metabolic stress signal that triggers the protective AMPK-mediated adaptive response — providing a specific mechanistic pathway for its metabolic effects.

Your MOTS-C plan, made simple

3-minute medical intake. Provider-led. 100% online.
Step 1
Complete your online consultation

You fill out a brief medical intake about your goals, symptoms, and health history. This helps your provider determine if MOTS-C is appropriate for you.

Step 2
Provider review & personalized plan

A licensed clinician reviews your case and creates a tailored BPC-157 plan based on your needs.

Step 3
Medication compounded & shipped to you

If approved, your MOTS-C medication is prepared by a U.S.-based compounding pharmacy and delivered directly to your door.

Step 4
Ongoing support inside your Shed portal

Ask questions, request adjustments, and get support anytime from your care team.

Shed FAQs

Questions? Answers.

Joining

Is MOTS-C FDA approved?

No. MOTS-C is investigational with no published human intervention trials yet. Shed is transparent about this being one of our most frontier protocols.
Joining

Do I need labs first?

Joining

How long is a protocol?

Joining

How is it delivered?